17 Belfield Road
Etobicoke
Toronto, ON M9W1E8
Canada
888 376 8258
https://www.psykeyworld.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 6
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Ms. Kate Monroe | Chief Executive Officer | N/A | N/A | N/A |
Mr. Amar Singh Bhatal | Co-Founder, President, Secretary & Director | N/A | N/A | N/A |
Mr. Sukhinderpaul Kalsi | Co-Founder, CFO, Treasurer & Director | N/A | N/A | N/A |
Jacqueline Rae Danforth | Compliance Officer & Accountant | N/A | N/A | N/A |
Mr. Mark Perkell | Vice President and General Counsel | N/A | N/A | N/A |
Mr. John Gustin | Head of Global Business Development | N/A | N/A | N/A |
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.
El ISS Governance QualityScore de Psykey, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.